Automated De Novo Monoclonal Antibody Sequencing for Modern Biotech

COPAN Diagnostics is pleased to release presentations given at an event held during ASM Microbe 2023. During this popular live event guests learned about the benefits of using technology for improved laboratory results and faster turnaround times.

Multicellular organisms and dynamic biological processes consist of a complex and coordinated interplay of multiple individual cells. Until recently, most molecular studies have relied on bulk analysis, combining all cells into a single average readout. In recent years, single-cell RNA sequencing technologies have enabled researchers to study development and disease at the level of individual cells, revealing cell-to-cell gene expression differences that were obscured with bulk or low throughput methods.

In the past decade, the synthetic biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules grows exponentially. The synthesis of DNA molecules and libraries has always been at the vanguard of synthetic biology endeavors but has seen its share of challenges that scientists have to navigate. Technological advancements and democratization of synthesis modalities have expanded access to an even wider range of life science investigators—presenting new challenges, but also a host of opportunities for new solutions.

How nuclear factor-erythroid factor 2-related factor 2 (Nrf2) affects the redox status of cells, The effects of cinnamic aldehyde treatment on Nrf2, Evidence for a Nrf2-dependent mechanism of neointimal hyperplasia inhibition by cinnamic aldehyde treatment and Benefits of 3D analysis of arterial injury over traditional 2D histology analysis